Webinars

Advances in Thyroid Cancer Diagnosis and Monitoring

Date: Friday, June 22, 2012

Author: Reitz, Richard, MD
Medical Director and Chair, Endocrinology
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA
  
Also by this Author 

Author: Waldman, Frederic, MD, PhD
Medical Director, Cancer Diagnostics
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA
  
Also by this Author 

Category: Webinar

Description: Richard Reitz, MD and Frederic Waldman, MD, PhD review current ATA guidelines and best practices for thyroid cancer testing, the use of cytomorphology with reflex to molecular testing for diagnosis, the clinical impact of fine-needle aspirate molecular testing and the role of thyroglobulin for post-treatment monitoring.

Content overview:
• Discuss the use of cytomorphology with reflex to molecular testing for the diagnosis of thyroid cancer
• Communicate the American Thyroid Association (ATA) thyroid cancer testing guidelines
• Discuss clinical impact of thyroid fine-needle aspirate (FNA) molecular testing
• Describe the role of thyroglobulin for post-treatment thyroid cancer monitoring